RNCOS Releases a New Report - Booming Pharma Sector in India
Released on: August 26, 2008, 5:10 am
Press Release Author: Shushmul Maheshwari
Industry: Healthcare
Press Release Summary: RNCOS has recently added a new Market Research Report titled, “Booming Pharma Sector in India”, to its report gallery. According to this report, in near future, the potential and opportunities within the pharmaceutical market in India will increase by several folds.
Press Release Body: RNCOS has recently added a new Market Research Report titled, “Booming Pharma Sector in India”, to its report gallery. India, a US$ 8.2 Billion pharmaceutical market, represents one of the most emerging pharmaceutical markets in the world.
According to the RNCOS latest report, in near future, the potential and opportunities within this market will increase by several folds. The market, presently driven by over a billion population, an expanding GDP, and rapid epidemiological transitions, is expected to be the major player in the global pharmaceutical market both in terms of its large domestic market and also as a pharmaceutical export hub.
The research study contains unique market-based research and provides detailed and objective analysis on the Indian pharmaceutical market. It presents a thorough statistical and analytical overview on the Indian pharmaceutical market, and provides past, present and future data on the entire structure, composition and working of the Indian pharmaceutical market. The research extensively discusses the opportunities and challenges that are expected to arise within and from the pharmaceutical market.
Research Highlights
- Between 2007-08 and 2011-12, the Indian domestic pharmaceutical market is expected to grow at a CAGR of nearly 16%. - The size of the domestic pharmaceutical market is larger than export market. However, owing to the growth of global generics market, stringent price controls in the domestic market, and better margins, the export market is growing much faster than the domestic market. - Traditional branded generics presently dominate the Indian pharmaceutical market but the future will see strong growth in the specialty branded generics and patented drug segments. - Drugs for diabetes and cardiovascular diseases are expected to see the fastest growth among all therapy areas during 2007-2011. - The retail pharmaceutical market in India is presently highly unorganized; however, a vast opportunity exists for the organized market. - Over the last few years, Cipla, Ranbaxy and GlaxoSmithKline are controlling the top three positions in the Indian pharmaceutical market.
The Report Covers
- Analysis of past, current and future market trends. - Market study by segment. - Discussion about the major drivers of the pharmaceutical market. - Analysis of opportunities created by the market. - Evaluation of major challenges for the market. - Review on the government regulations. - Competitive landscape of the market.
Research Methodology Used
Information Sources Information has been sourced from books, newspapers, trade journals, white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.
Analysis Methods The analysis methods include ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today\'s globally competitive environment.
For more information visit: http://www.rncos.com/Report/IM131.htm Current Industry News: http://www.rncos.com/Blog/
2012
